Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:15 pm Purchase | 2023-12-31 | 13G | Morphic Holding, Inc. MORF | Point72 Asset Management, L.P. | 4,591,000 9.200% | 2,086,617![]() (+83.32%) | Filing History |
| 2024-02-14 4:14 pm Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Point72 Asset Management, L.P. | 3,416,900 5.100% | -311,052![]() (-8.34%) | Filing History |
| 2024-02-14 4:14 pm Purchase | 2023-12-31 | 13G | Cybin Inc. CYBN | Point72 Asset Management, L.P. | 791,082 7.400% | 791,082![]() (New Position) | Filing History |
| 2024-02-14 4:13 pm Purchase | 2023-12-31 | 13G | Health Catalyst, Inc. HCAT | Point72 Asset Management, L.P. | 4,159,454 7.200% | 1,334,524![]() (+47.24%) | Filing History |
| 2024-02-14 4:12 pm Purchase | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 758,185 8.600% | 758,185![]() (New Position) | Filing History |
| 2024-02-14 4:11 pm Purchase | 2023-12-31 | 13G | Cogent Biosciences, Inc. COGT | Point72 Asset Management, L.P. | 5,243,623 6.100% | 1,680,721![]() (+47.17%) | Filing History |
| 2024-02-14 4:10 pm Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | Point72 Asset Management, L.P. | 4,040,000 9.400% | 1,918,830![]() (+90.46%) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Point72 Asset Management, L.P. | 493,400 0.900% | -3,021,956![]() (-85.96%) | Filing History |
| 2024-02-14 10:06 am Sale | 2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Point72 Asset Management, L.P. | 3,974,873 4.200% | -3,727,958![]() (-48.40%) | Filing History |
| 2024-02-14 10:04 am Sale | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 65,754 1.700% | -185,512![]() (-73.83%) | Filing History |
| 2024-02-14 10:03 am Sale | 2023-12-31 | 13G | Eos Energy Enterprises, Inc. EOSE | Point72 Asset Management, L.P. | 3,840,704 2.000% | -1,694,326![]() (-30.61%) | Filing History |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 62,511 1.400% | -130,889![]() (-67.68%) | Filing History |
| 2024-02-14 10:02 am Purchase | 2023-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | Point72 Asset Management, L.P. | 2,500 0.300% | 2,500![]() (New Position) | Filing History |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | AnaptysBio, Inc. ANAB | Point72 Asset Management, L.P. | 788,545 3.000% | -1,335,655![]() (-62.88%) | Filing History |
| 2024-02-14 08:56 am Sale | 2023-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Point72 Asset Management, L.P. | 822,334 3.000% | -743,495![]() (-47.48%) | Filing History |
| 2024-02-14 07:16 am Purchase | 2023-12-31 | 13G | FARFETCH LTD FTCHQ | Point72 Asset Management, L.P. | 20,383,303 5.800% | 1,617,894![]() (+8.62%) | Filing History |
| 2024-02-14 07:15 am Sale | 2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 2,613,453 4.500% | -572,624![]() (-17.97%) | Filing History |
| 2024-02-14 07:15 am Sale | 2023-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Point72 Asset Management, L.P. | 3,202,381 4.700% | -268,310![]() (-7.73%) | Filing History |
| 2024-02-14 07:01 am Purchase | 2023-12-31 | 13G | Semtech Corporation SMTC | Point72 Asset Management, L.P. | 1,684,160 2.600% | 1,684,160![]() (New Position) | Filing History |
| 2024-02-14 07:01 am Sale | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 2,834,499 3.300% | -685,903![]() (-19.48%) | Filing History |

